CAVALERI DANIELE

Riboldi, I., Cavaleri, D., Morreale, M., Crocamo, C., Bartoli, F., Carrà, G. (2025). Clinical and biochemical factors associated with hyperammonemia in inpatients with mental disorders treated with valproic acid: a cross-sectional analysis. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 15, 1-13 [10.1177/20451253251385730]. Detail

Cavaleri, D., Riboldi, I., Bartoli, F. (2025). The Promise of Long-acting Injectable Antipsychotics for the Treatment of Bipolar I Disorder: The Role of Manic Predominance. ACTAS ESPAÑOLAS DE PSIQUIATRÍA, 53(5), 1157-1159 [10.62641/aep.v53i5.1976]. Detail

Bartoli, F., Cavaleri, D., Riboldi, I., Callovini, T., Crocamo, C., Gastaldon, C., et al. (2025). Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study. DRUGS & AGING, 42(8), 771-780 [10.1007/s40266-025-01231-3]. Detail

Crocamo, C., Palpella, D., Cavaleri, D., Nasti, C., Piacenti, S., Morello, P., et al. (2025). Digital health interventions for mental health disorders: an umbrella review of meta-analyses of randomised controlled trials. THE LANCET. DIGITAL HEALTH, 7(8) [10.1016/j.landig.2025.100878]. Detail

Cavaleri, D., Barbieri, F., Bartoccetti, A., Manzato, M., Toscano, M., Carrà, G., et al. (2025). Rapid-onset black hairy tongue following clomipramine initiation and rechallenge: A case report. PSYCHIATRY RESEARCH. CASE REPORTS, 4(2 (December 2025)) [10.1016/j.psycr.2025.100289]. Detail